Cancer of Skin

2

Review clinical trials related to Cancer of Skin. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Mobile Health Intervention Among Hispanics

Hypothesis: More than 80% of the participants (n=40) will complete the intervention at three month (intervention completion) and the six month follow-up (retention rate as feasibility). More than 70% of the participants will report high overall study satisfaction (acceptability) with the intervention and study. This pre-pilot will inform intervention and procedural refinements for the pilot. Hypothesis: Participants who receive the intervention (n=57) will report more skin cancer-related preventive behaviors (e.g., mean of summed score of sun protection behaviors such as use of sunscreen, etc.) at three month and six month follow-up compared to those in the control condition (n=57, who will receive general information about physical activity and nutrition).

Participants needed: 114
Trial details
Age: 18-100Biological sex: AllType: InterventionalSponsor: Rutgers, The State University of New JerseyUpdated: Dec 16, 2025Locations: 1
Eligibility criteria

Self-report as Hispanics [+6]

Currently being treated for melanoma or nonmelanoma skin cancer

Status: Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.

Participants needed: 50,000
Trial details
Biological sex: AllType: ObservationalSponsor: Massive Bio, Inc.Updated: Oct 28, 2025Locations: 68Duration: 36 Months
Eligibility criteria

Pts with solid and hematological malignancies; [+2]

ECOG PS > 2; [+2]